Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicine company, it uses innovative science and digital technologies to create transformative treatments in areas of great medical need. In its quest to find new medicines, Novartis consistently ranks among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and the company is finding innovative ways to expand access to its latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world.
Health equity is key because social factors account for 80-90% of health outcomes. Here's how cities can use data and density to bolster health equity.
If the pharmaceutical industry collaborates with public healthcare systems on preventative health, together they could improve patient health worldwide.
Data science and technology can improve human health in all corners of the world for the duration of the pandemic and beyond.
The Centre for Advanced Manufacturing and Supply Chains is enabling more resilient, sustainable and inclusive manufacturing ecosystems and supply chains.
The Centre for Health and Healthcare is identifying and scaling up solutions for more resilient, efficient, and equitable healthcare systems.
The Centre for the New Economy and Society is providing a platform for leaders to shape inclusive and equitable economies and societies that create opportunity for all.
The Centre for Urban Transformation is advancing public-private collaboration in cities, enabling more resilient and future-ready communities and local economies.
